Bottom line
What does JFNAX hold?
JFNAX held 108 positions as of Jun 30, 2026. Its largest holding is Eli Lilly & Co. at 9.41% of the fund, and the top 10 positions add up to 42.4%. By asset type it is 99% stocks, 1% cash & short-term funds.
Updated Aug 26, 2026
JFNAX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co. | Stocks | 9.41% | $546.4M |
| 2 | Johnson & Johnson | Stocks | 7.09% | $411.8M |
| 3 | AbbVie, Inc. | Stocks | 4.67% | $271.0M |
| 4 | UnitedHealth Group, Inc. | Stocks | 4.54% | $263.6M |
| 5 | AstraZeneca plc | Stocks | 3.93% | $228.3M |
| 6 | Revolution Medicines, Inc. | Stocks | 3.02% | $175.4M |
| 7 | Argenx SE | Stocks | 2.63% | $152.7M |
| 8 | Novartis AG | Stocks | 2.56% | $148.8M |
| 9 | Thermo Fisher Scientific, Inc. | Stocks | 2.33% | $135.4M |
| 10 | Praxis Precision Medicines, Inc. | Stocks | 2.19% | $127.0M |
| 11 | Bridgebio Pharma, Inc. | Stocks | 2.04% | $118.5M |
| 12 | CVS Health Corp. | Stocks | 2.02% | $117.2M |
| 13 | Roche Holding AG | Stocks | 2.01% | $116.9M |
| 14 | Intuitive Surgical, Inc. | Stocks | 1.94% | $112.9M |
| 15 | Merck & Co., Inc. | Stocks | 1.87% | $108.8M |
| 16 | Abbott Laboratories | Stocks | 1.86% | $108.3M |
| 17 | Vertex Pharmaceuticals, Inc. | Stocks | 1.69% | $98.3M |
| 18 | Ascendis Pharma A/S | Stocks | 1.68% | $97.5M |
| 19 | Danaher Corp. | Stocks | 1.65% | $95.7M |
| 20 | Amgen, Inc. | Stocks | 1.64% | $95.1M |
| 21 | Sanofi SA | Stocks | 1.58% | $91.8M |
| 22 | Stryker Corp. | Stocks | 1.41% | $82.0M |
| 23 | PTC Therapeutics, Inc. | Stocks | 1.40% | $81.2M |
| 24 | Gilead Sciences, Inc. | Stocks | 1.39% | $80.5M |
| 25 | Travere Therapeutics, Inc. | Stocks | 1.38% | $80.3M |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 26, 2026